Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of HRS-7450 Injection in acute ischemic stroke
CTR20254134Phase 2Active
- Sponsor
- Fujian Shengdi Pharmaceuticals
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7450 in ischemic stroke, sponsored by Fujian Shengdi Pharmaceuticals. Started Oct 2025; status: active.
02
Drugs
HRS-7450
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20254134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254134.